Shanghai Xuanyu Medical Receives 2024 Chinese Healthcare Front-Runners Award in Medical Devices

Award Details

2024 China Biomedical Leaders List

In October 2023, the inaugural "2023 China Biomedical Front-Runners" list was released for the first time, highlighting a group of benchmark companies in the three fields of biomedicine, medical devices, and digital healthcare. This generated widespread attention and discussion across society. The release of the Front-Runners list represents a significant initiative to capture forward-looking trends, explore technological frontiers, and establish an industry "barometer."

Compared with last year, this year's list selection process remains consistent with the core values of innovation and value pursuit upheld by the leading companies in the biopharmaceutical industry. In terms of organization, there is a stronger emphasis on enhancing influence and continuously expanding partnerships. Collaborating with Shanghai Biomedical Fund, Shanghai SDIC Pioneer, Qiming Venture Partners, Boyuan Capital, Haitong Securities, Shanghai Frontier, ShinCher BioStar Port, and ATLATL Innovation Center to build an ecosystem synergy, while linking up with Yicai Media Group, PharmaCube, R&D Guest, DrugTimes, and tmtpost to form a media matrix.

List Details

Medical Device Rankings

The medical device list focuses on innovative devices as its core business, covering non-listed companies in the fields of implantable and interventional devices, in vitro diagnostic instruments and reagents, medical imaging devices, surgical instruments, diagnostic and monitoring devices, rehabilitation devices, assisted reproductive devices, and other medical devices.

This list is divided into four categories based on quantitative values: Outstanding Leaders, Innovation Pioneers, Future Explorers, and Rising Stars. Among them, Outstanding Leaders aims to recognize companies with exceptional leadership and influence in the industry; Innovation Pioneers aims to showcase companies that are trendsetters in innovative fields; Future Explorers aims to identify companies that may achieve significant breakthroughs in the future; Rising Stars aims to highlight companies with excellent market performance and rapid growth. The ranking within each category is not in any particular order.

ShineyoMedical

ShineyoMedical focuses on the development of innovative Class III high-risk medical devices for the new generation of cardiovascular minimally invasive interventional treatments, committed to providing internationally leading disease treatment solutions for cardiovascular patients in China. The company's product pipeline is extensive, covering a variety of innovative products for the treatment of heart and vascular diseases, with enormous market potential.